Bruker Corp
BRKR33.260USD
+1.190+3.71%
Cierre 09/16, 16:00（ET）Cotizaciones retrasadas 15 min
5.05BCap. mercado
63.39P/E TTM
Más Datos de Bruker Corp Compañía
Bruker Corporation is a developer, manufacturer and distributor of scientific instruments and analytical and diagnostic solutions. Its BSI BioSpin segment designs, manufactures, and distributes enabling life science tools based on magnetic resonance technology. Its BSI CALID segment designs, manufactures and distributes life science mass spectrometry and ion mobility spectrometry solutions, analytical and process analysis instruments and solutions. Its BSI Nano segment designs, manufactures and distributes advanced X-ray instruments, atomic force microscopy instrumentation, advanced fluorescence optical microscopy instruments. Its Bruker Energy & Supercon Technologies (BEST) segment develops and manufactures superconducting and non-superconducting materials and devices for use in renewable energy, energy infrastructure, healthcare and big science research. Its product lines include nCounter, CosMx, GeoMx and AtoMx. It also owns electron paramagnetic resonance (EPR) business.
Información de la empresa
Símbolo de cotizaciónBRKR
Nombre de la empresaBruker Corp
Fecha de salida a bolsaAug 04, 2000
Director ejecutivoDr. Burkhard A. Prause, Ph.D.
Número de empleados11396
Tipo de seguridadOrdinary Share
Fin del año fiscalAug 04
Dirección40 Manning Rd
CiudadBILLERICA
Bolsa de valoresNASDAQ Global Select Consolidated
PaísUnited States of America
Código postal01821-3915
Teléfono19786633660
Sitio Webhttps://www.bruker.com/
Símbolo de cotizaciónBRKR
Fecha de salida a bolsaAug 04, 2000
Director ejecutivoDr. Burkhard A. Prause, Ph.D.
Ejecutivos de la empresa
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Dr. Frank H. Laukien, Ph.D.
Dr. Frank H. Laukien, Ph.D.
Chairman of the Board, President, Chief Executive Officer
Chairman of the Board, President, Chief Executive Officer
40.41M
+0.08%
Dr. Mark Robert Munch, Ph.D.
Dr. Mark Robert Munch, Ph.D.
Executive Vice President, President of Bruker Nano Group and Bruker Nano Surfaces Division
Executive Vice President, President of Bruker Nano Group and Bruker Nano Surfaces Division
95.36K
+24.98%
Mr. Richard A. Packer
Mr. Richard A. Packer
Independent Director
Independent Director
80.90K
-1.13%
Mr. Gerald N. Herman
Mr. Gerald N. Herman
Chief Financial Officer, Executive Vice President
Chief Financial Officer, Executive Vice President
70.13K
+41.65%
Dr. Falko Busse, Ph.D.
Dr. Falko Busse, Ph.D.
President - Bruker BioSpin Group
President - Bruker BioSpin Group
35.59K
+35.29%
Mr. John A. Ornell, CPA
Mr. John A. Ornell, CPA
Independent Director
Independent Director
28.15K
+21.60%
Dr. Hermann Fritz Requardt, Ph.D.
Dr. Hermann Fritz Requardt, Ph.D.
Independent Director
Independent Director
23.15K
-3.83%
Ms. Adelene Q. Perkins
Ms. Adelene Q. Perkins
Independent Director
Independent Director
21.33K
-4.14%
Dr. Cynthia M. Friend, Ph.D.
Dr. Cynthia M. Friend, Ph.D.
Independent Director
Independent Director
14.72K
+5.48%
Ms. Bonnie H. Anderson
Ms. Bonnie H. Anderson
Independent Director
Independent Director
10.03K
-8.41%
Ver más
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Dr. Frank H. Laukien, Ph.D.
Dr. Frank H. Laukien, Ph.D.
Chairman of the Board, President, Chief Executive Officer
Chairman of the Board, President, Chief Executive Officer
40.41M
+0.08%
Dr. Mark Robert Munch, Ph.D.
Dr. Mark Robert Munch, Ph.D.
Executive Vice President, President of Bruker Nano Group and Bruker Nano Surfaces Division
Executive Vice President, President of Bruker Nano Group and Bruker Nano Surfaces Division
95.36K
+24.98%
Mr. Richard A. Packer
Mr. Richard A. Packer
Independent Director
Independent Director
80.90K
-1.13%
Mr. Gerald N. Herman
Mr. Gerald N. Herman
Chief Financial Officer, Executive Vice President
Chief Financial Officer, Executive Vice President
70.13K
+41.65%
Dr. Falko Busse, Ph.D.
Dr. Falko Busse, Ph.D.
President - Bruker BioSpin Group
President - Bruker BioSpin Group
35.59K
+35.29%
Mr. John A. Ornell, CPA
Mr. John A. Ornell, CPA
Independent Director
Independent Director
28.15K
+21.60%
Desglose de ingresos
Divisa: USDActualizado: dom., 6 de jul
Divisa: USDActualizado: dom., 6 de jul
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021
FY2020
FY2019
Por negocioUSD
Nombre
Ganancia
Proporción
Product
643.30M
80.27%
Product And Service Other
158.10M
19.73%
Service and other revenue
158.10M
19.73%
Por regiónUSD
Nombre
Ganancia
Proporción
Rest of Europe
224.10M
27.96%
United States
217.40M
27.13%
Rest of Asia Pacific
131.40M
16.40%
China
101.20M
12.63%
Other
66.20M
8.26%
Germany
61.10M
7.62%
Por negocio
Por región
Por negocioUSD
Nombre
Ganancia
Proporción
Product
643.30M
80.27%
Product And Service Other
158.10M
19.73%
Service and other revenue
158.10M
19.73%
Estadísticas de accionistas
Actualizado: mar., 19 de ago
Actualizado: mar., 19 de ago
Accionistas
Tipos de accionistas
Accionistas
Accionistas
Proporción
Laukien (Frank H)
26.64%
T. Rowe Price Investment Management, Inc.
7.53%
The Vanguard Group, Inc.
6.86%
Pallas Capital Advisors LLC
6.26%
BlackRock Institutional Trust Company, N.A.
6.20%
Otro
46.51%
Accionistas
Accionistas
Proporción
Laukien (Frank H)
26.64%
T. Rowe Price Investment Management, Inc.
7.53%
The Vanguard Group, Inc.
6.86%
Pallas Capital Advisors LLC
6.26%
BlackRock Institutional Trust Company, N.A.
6.20%
Otro
46.51%
Tipos de accionistas
Accionistas
Proporción
Investment Advisor
49.40%
Individual Investor
32.01%
Investment Advisor/Hedge Fund
22.53%
Hedge Fund
6.56%
Research Firm
2.16%
Pension Fund
1.51%
Bank and Trust
1.29%
Sovereign Wealth Fund
0.77%
Insurance Company
0.21%
Participación institucional
Actualizado: mar., 1 de jul
Actualizado: mar., 1 de jul
Periodo del informe
Número de instituciones
Acciones mantenidas
Proporción
Cambio
2025Q2
898
171.75M
113.23%
-7.16M
2025Q1
907
173.24M
114.51%
-5.44M
2024Q4
874
174.12M
114.80%
+488.91K
2024Q3
832
169.17M
111.74%
-784.20K
2024Q2
803
166.71M
111.27%
+3.25M
2024Q1
787
160.55M
116.07%
-746.16K
2023Q4
764
159.55M
114.90%
-2.81M
2023Q3
739
159.71M
108.74%
-10.40M
2023Q2
728
167.57M
114.19%
+11.26M
2023Q1
709
153.65M
104.63%
-3.11M
Ver más
Actividad de los accionistas
Nombre
Acciones mantenidas
Proporción
Cambio
Cambio %
Fecha
Laukien (Frank H)
40.38M
26.65%
+2.61K
+0.01%
Jun 06, 2025
T. Rowe Price Investment Management, Inc.
12.38M
8.17%
-11.64K
-0.09%
Mar 31, 2025
The Vanguard Group, Inc.
10.53M
6.95%
-100.66K
-0.95%
Mar 31, 2025
Pallas Capital Advisors LLC
9.50M
6.27%
+13.38K
+0.14%
Mar 31, 2025
BlackRock Institutional Trust Company, N.A.
10.20M
6.73%
+180.04K
+1.80%
Mar 31, 2025
Laukien (Joerg C)
7.52M
4.96%
--
--
Apr 01, 2025
Fidelity Management & Research Company LLC
9.82M
6.48%
-2.89M
-22.75%
Mar 31, 2025
The London Company of Virginia, LLC
4.14M
2.73%
-54.48K
-1.30%
Mar 31, 2025
State Street Global Advisors (US)
3.83M
2.53%
+33.25K
+0.88%
Mar 31, 2025
Ver más
ETFs relacionados
Actualizado: sáb., 6 de sep
Actualizado: sáb., 6 de sep
Nombre
Proporción
First Trust NYSE Arca Biotechnology Index Fund
2.6%
AB Disruptors ETF
0.89%
SPDR S&P Kensho New Economies Composite ETF
0.57%
iShares Biotechnology ETF
0.34%
Vanguard S&P Mid-Cap 400 Index Fund
0.14%
SPDR S&P Midcap 400 ETF
0.14%
SPDR Portfolio S&P 400 Mid Cap ETF
0.13%
iShares Core S&P Mid-Cap ETF
0.13%
Schwab Fundamental U.S. Small Company ETF
0.11%
iShares S&P Mid-Cap 400 Growth ETF
0.1%
Ver más
First Trust NYSE Arca Biotechnology Index Fund
Proporción2.6%
AB Disruptors ETF
Proporción0.89%
SPDR S&P Kensho New Economies Composite ETF
Proporción0.57%
iShares Biotechnology ETF
Proporción0.34%
Vanguard S&P Mid-Cap 400 Index Fund
Proporción0.14%
SPDR S&P Midcap 400 ETF
Proporción0.14%
SPDR Portfolio S&P 400 Mid Cap ETF
Proporción0.13%
iShares Core S&P Mid-Cap ETF
Proporción0.13%
Schwab Fundamental U.S. Small Company ETF
Proporción0.11%
iShares S&P Mid-Cap 400 Growth ETF
Proporción0.1%
Dividendos
Un total de
138.20M
USD se ha distribuido en dividendos durante los últimos 5 años.
Fecha
Dividendos
Fecha de registro
Fecha de pago
Fecha ex-dividendo
Feb 21, 2025
BRKR.NB Interim Cash Dividend of gross USD 0.05 paid on Mar 28, 2025 going ex on Mar 17, 2025
Mar 17, 2025
Mar 28, 2025
Mar 17, 2025
Nov 18, 2024
BRKR.NB Final Cash Dividend of gross USD 0.05 paid on Dec 16, 2024 going ex on Dec 02, 2024
Dec 02, 2024
Dec 16, 2024
Dec 02, 2024
Aug 14, 2024
BRKR.NB Interim Cash Dividend of gross USD 0.05 paid on Sep 16, 2024 going ex on Aug 30, 2024
Sep 02, 2024
Sep 16, 2024
Aug 30, 2024
May 15, 2024
BRKR.NB Interim Cash Dividend of gross USD 0.05 paid on Jun 17, 2024 going ex on Jun 03, 2024
Jun 03, 2024
Jun 17, 2024
Jun 03, 2024
Feb 16, 2024
BRKR.NB Interim Cash Dividend of gross USD 0.05 paid on Mar 15, 2024 going ex on Feb 29, 2024
Mar 01, 2024
Mar 15, 2024
Feb 29, 2024
Nov 20, 2023
BRKR.NB Final Cash Dividend of gross USD 0.05 paid on Dec 15, 2023 going ex on Nov 30, 2023
Dec 01, 2023
Dec 15, 2023
Nov 30, 2023
Aug 14, 2023
BRKR.NB Interim Cash Dividend of gross USD 0.05 paid on Sep 15, 2023 going ex on Aug 31, 2023
Sep 01, 2023
Sep 15, 2023
Aug 31, 2023
May 15, 2023
BRKR.NB Interim Cash Dividend of gross USD 0.05 paid on Jun 16, 2023 going ex on May 31, 2023
Jun 01, 2023
Jun 16, 2023
May 31, 2023
Feb 17, 2023
BRKR.NB Interim Cash Dividend of gross USD 0.05 paid on Mar 17, 2023 going ex on Feb 28, 2023
Mar 01, 2023
Mar 17, 2023
Feb 28, 2023
Nov 11, 2022
BRKR.NB Final Cash Dividend of gross USD 0.05 paid on Dec 16, 2022 going ex on Nov 30, 2022
Dec 01, 2022
Dec 16, 2022
Nov 30, 2022
Ver más
División de acciones
Fecha
Tipo
Relación
Sin datos
Fecha
Tipo
Relación
Sin datos
